{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:04:07Z","timestamp":1792555447165,"version":"4.5.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous genetic and epidemiological studies have examined subpopulations from the Canadian Collaborative Project on Genetic Susceptibility to Multiple Sclerosis (CCPGSMS) patient cohort, but an encompassing analysis of the study population has not yet been carried out.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This retrospective study examines patterns of multiple sclerosis (MS) prevalence in 13,663 cohort members, including 4,821 persons with MS or suspected MS and 8,842 family members.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We grouped participants into epidemiologic subgroups based on age of MS onset, clinical stage at diagnosis, symptom type at disease onset, sex, proband status, disability as measured by the EDSS, and ancestry based on reported ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed a 2.7:1 MS prevalence ratio of women to men, though disease severity was greater for male patients. Variation in the age of disease onset between patients was only slightly associated with sex and strongly associated with disease type. Specific types of clinical symptoms at disease onset were associated with the prognosis. Regional residence did not correlate with disease onset, type, or severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Population trends, as presented here, are not explained by environmental factors alone, highlighting the need for a comprehensive genetic analysis to understand disease variance across families.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fneur.2025.1509371","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:15:46Z","timestamp":1741133746000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["The Canadian collaborative project on genetic susceptibility to multiple sclerosis cohort population structure and disease etiology"],"prefix":"10.3389","volume":"16","author":[{"given":"Alison M.","family":"Pagalilauan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Everest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna","family":"Rachimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D.","family":"Waldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Dessa","family":"Sadovnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Vilarino-Guell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Lenardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple Sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/WCO.0000000000000094","article-title":"Relapsing and progressive forms of multiple sclerosis: insights from pathology","volume":"27","author":"Dutta","year":"2014","journal-title":"Curr Opin Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"s53","DOI":"10.7861\/clinmedicine.16-6-s53","article-title":"Multiple sclerosis, a treatable disease","volume":"16","author":"Doshi","year":"2016","journal-title":"Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.autrev.2011.05.007","article-title":"Genetic background of multiple sclerosis","volume":"11","author":"Sadovnick","year":"2012","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/13524585211020221","article-title":"Genes and environment in multiple sclerosis: impact of temporal changes in the sex ratio on recurrence risks","volume":"28","author":"Sadovnick","year":"2022","journal-title":"Mult Scler J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","article-title":"Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition","volume":"26","author":"Walton","year":"2020","journal-title":"Mult Scler"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1093\/brain\/awab104","article-title":"The latitude gradient for multiple sclerosis prevalence is established in the early life course","volume":"144","author":"Sabel","year":"2021","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3181\/00379727-216-44153A","article-title":"Vitamin D and multiple sclerosis","volume":"216","author":"Hayes","year":"1997","journal-title":"Exp Biol Med"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1212676","DOI":"10.3389\/fimmu.2023.1212676","article-title":"Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection","volume":"14","author":"Hedstr\u00f6m","year":"2023","journal-title":"Front Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1212\/WNL.0000000000002469","article-title":"Multiple sclerosis prevalence in the United States commercially insured population","volume":"86","author":"Dilokthornsakul","year":"2016","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1212\/WNL.0b013e3181cf6ec0","article-title":"The rising prevalence and changing age distribution of multiple sclerosis in Manitoba","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1212\/WNL.0b013e3181e24124","article-title":"Multiple sclerosis, vitamin D, and HLA-DRB1*15","volume":"74","author":"Handunnetthi","year":"2010","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1177\/1352458512451942","article-title":"Epstein-Barr virus, latitude and multiple sclerosis","volume":"19","author":"Disanto","year":"2013","journal-title":"Mult Scler"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41598-022-04836-5","article-title":"Age-period-cohort analysis of the incidence of multiple sclerosis over twenty years in Lorraine, France","volume":"12","author":"Gbaguidi","year":"2022","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1399-0039.1995.tb02503.x","article-title":"The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes DRB5*0101 allele","volume":"46","author":"Fogdell","year":"1995","journal-title":"Tissue Antigens"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e29819","DOI":"10.1371\/journal.pone.0029819","article-title":"Multiple sclerosis risk variant HLA-DRB1*1501 associates with high expression of DRB1 gene in different human populations","volume":"7","author":"Alcina","year":"2012","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1017\/S0317167100034041","article-title":"Canadian collaborative project on genetic susceptibility to MS, phase 2: rationale and method","volume":"25","author":"Sadovnick","year":"1998","journal-title":"Can J Neurol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.neuron.2016.04.039","article-title":"Nuclear Receptor NR1H3 in Familial Multiple Sclerosis","volume":"90","author":"Wang","year":"2016","journal-title":"Neuron"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.clim.2017.05.009","article-title":"Genetic modifiers of multiple sclerosis progression, severity and onset","volume":"180","author":"Sadovnick","year":"2017","journal-title":"Clin Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for MS: guidelines from the international panel on the diagnosis of MS","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2017","journal-title":"Lancet Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1177\/1352458517690618","article-title":"Age related multiple sclerosis severity score: disability ranked by age","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"Mult Scler"},{"key":"ref25","author":"Von Bergmann","year":"2022"},{"key":"ref26","year":"2022"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s00415-006-0161-8","article-title":"Benign multiple sclerosis","volume":"253","author":"Amato","year":"2006","journal-title":"J Neurol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e0287463","DOI":"10.1371\/journal.pone.0287463","article-title":"Prospective outcome analysis of multiple sclerosis cases reveals candidate prognostic cerebrospinal fluid markers","volume":"18","author":"Everest","year":"2023","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1352458512451510","article-title":"Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis","volume":"19","author":"Tutuncu","year":"2013","journal-title":"Mult Scler J"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/brain\/awt356","article-title":"Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden","volume":"137","author":"Westerlind","year":"2014","journal-title":"Brain"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"e0122686","DOI":"10.1371\/journal.pone.0122686","article-title":"Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS","volume":"10","author":"Ribbons","year":"2015","journal-title":"PLoS One"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.msard.2017.02.010","article-title":"Incidence of multiple sclerosis in the Republic of Ireland: a prospective population-based study","volume":"13","author":"O\u2019Connell","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/7854_2015_371","article-title":"Sex-based differences in multiple sclerosis (part I): biology of disease incidence","volume":"26","author":"Dunn","year":"2015","journal-title":"Curr Top Behav Neurosci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"8024","DOI":"10.1073\/pnas.0600536103","article-title":"Evidence that the Y chromosome influences autoimmune disease in male and female mice","volume":"103","author":"Teuscher","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jocn.2020.02.017","article-title":"Location of first attack predicts the site of subsequent relapses in multiple sclerosis","volume":"74","author":"Tsantes","year":"2020","journal-title":"J Clin Neurosci"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1177\/1352458514528762","article-title":"Risk of relapse phenotype recurrence in multiple sclerosis","volume":"20","author":"Kalincik","year":"2014","journal-title":"Mult Scler J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000082141","article-title":"Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones","volume":"26","author":"Marin-Husstege","year":"2004","journal-title":"Dev Neurosci"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1007\/s00415-019-09413-x","article-title":"Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010-2017: findings from the Scottish multiple sclerosis register","volume":"266","author":"Kearns","year":"2019","journal-title":"J Neurol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1191\/1352458505ms1192oa","article-title":"Regional variation of multiple sclerosis in Canada","volume":"11","author":"Beck","year":"2005","journal-title":"Mult Scler"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e48078","DOI":"10.1371\/journal.pone.0048078","article-title":"Geographical variations in sex ratio trends over time in multiple sclerosis","volume":"7","author":"Trojano","year":"2012","journal-title":"PLoS One"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1509371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:15:50Z","timestamp":1741133750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1509371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":40,"alternative-id":["10.3389\/fneur.2025.1509371"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1509371","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.04.18.24305992","asserted-by":"object"}]},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"article-number":"1509371"}}